infant-monitors

1. October 9, 2026News2 receipts2 min

   FDA codifies infant oxygen monitor controls covering performance, caregiver understanding and instructions about their limits

   An October 9 FDA order puts controls for over-the-counter infant pulse and oxygen monitors into federal regulations. It codifies a classification that applied in November 2023, rather than announcing a new product approval. The controls require testing across expected users and conditions, including skin pigmentation, and instructions that help caregivers interpret readings and understand appropriate actions.

   Also filed underhealthmedical-devicesconsumer-protectionfdafederal-register

2. October 9, 2026Commentary3 receipts4 min

   An infant monitor can give you a number. That is not a promise to keep a baby safe.

   FDA's October 9 order codifies the existing class II classification for infant pulse and oxygen monitors, with special controls. The controls include testing whether caregivers can interpret the output and act on it. Read alongside the agency's earlier warning on infant monitors, the distinction is plain: an authorized measurement is not authorization to claim prevention of sudden infant death. The useful question is what the device is allowed to tell you, and what it cannot promise.

   Also filed undermedical-devicesfdaproduct-claimspublic-record

A record appears here because it carries infant-monitors in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.